The medical device maker received a warning letter from the FDA, which said Abiomed (ABMD) is making marketing claims about its heart pump without approval. Claims such as "Recovering Hearts. Saving Lives." for its Impella Recover LP 2.5 heart pump appear on the company's website, even though they aren't supported by randomized clinical studies. The pump has been OK'd for some cases when patients need partial circulatory support. Shares fell 5% to
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Health CareHealth Care Equipment
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in